ASX · AVR.AX
Anteris Technologies Ltd
A$8.83+A$0.28 (+3.27%)
Anteris Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.92% below the high.
Loading market information…
OTC · LFLY · USD
Stock price, earnings
Quote as of Sep 24, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Leafly Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Leafly Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Leafly Holdings, Inc. manages a comprehensive online platform that serves as a primary resource for cannabis consumers, offering in-depth information while also linking them with licensed retailers and various cannabis brands. The company provides cannabis businesses, such as retailers and brands, with a suite of services including premium marketplace placements, digital advertising opportunities, and cloud-based software tools. Concurrently, it empowers its user base with critical product details, customer reviews, current menus, and convenient functionalities for ordering and delivery, all accessible through its website and dedicated mobile applications. The firm was established in 2010 and maintains its corporate headquarters in Seattle, Washington.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2023 | Nov 9, 2023 | -$1.10+8.33% vs estimate | $10.58M+11.52% vs estimate |
|---|
| Q2 2023 | Aug 10, 2023 | -$0.80+55.56% vs estimate | $10.68M+3.94% vs estimate |
|---|
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$8.83+A$0.28 (+3.27%)
Anteris Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.92% below the high.
£2.04£0.00 (0.0%)
Diaceutics PLC’s quoted price sits in the upper half of its reported 52-week range, 3.1% below the high.
$0.12$0.00 (0.0%)
Creso Pharma Limited: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.43$0.00 (0.0%)
Cell MedX Corp.: Healthcare · Medical - Devices.
HK$0.90HK$0.00 (0.0%)
Tian An Medicare Limited’s quoted price sits in the lower half of its reported 52-week range, 34.19% below the high.
¥586-¥1 (-0.17%)
Japan Medical Dynamic Marketing, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.69% below the high.
A$0.05-A$0.00 (-3.64%)
Prescient Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 57.6% below the high.
$1.66-$0.10 (-5.68%)
BioHarvest Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.4% below the high.
